| Reference |
|---|
Li X, Zhang J, Wang X, Pu D, Zhang Z, Niu Y, et al. Human induced pluripotent stem cell line XXMUFAi001-A generated from a patient harboring KCNH2 mutation (c. 2690 A>C). Stem Cell Res. 2025;82:103635 pubmed publisher |
Tsuchiya J, Miyoshi M, Kakinuma S, Kawai Kitahata F, Kamiya A, Shimizu T, et al. Hepatitis B Virus-KMT2B Integration Drives Hepatic Oncogenic Processes in a Human Gene-edited Induced Pluripotent Stem Cells-derived Model. Cell Mol Gastroenterol Hepatol. 2025;19:101422 pubmed publisher |
L xe1 szl xf3 L, Maczelka H, Tak xe1 cs T, Kurilla A, Tilajka x, Buday L, et al. A Novel Cell-Based Model for a Rare Disease: The Tks4-KO Human Embryonic Stem Cell Line as a Frank-Ter Haar Syndrome Model System. Int J Mol Sci. 2022;23: pubmed publisher |
Jewell B, Xu A, Zhu D, Huang M, Lu L, Liu M, et al. Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome. PLoS Genet. 2021;17:e1009971 pubmed publisher |
Iwamoto Y, Seki Y, Taya K, Tanaka M, Iriguchi S, Miyake Y, et al. Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease. Mol Ther Methods Clin Dev. 2021;21:262-273 pubmed publisher |
Hathy E, Szabó E, Vincze K, Haltrich I, Kiss E, Varga N, et al. Generation of multiple iPSC clones from a male schizophrenia patient carrying de novo mutations in genes KHSRP, LRRC7, and KIR2DL1, and his parents. Stem Cell Res. 2021;51:102140 pubmed publisher |
Okamoto S, Amaishi Y, Maki I, Enoki T, Mineno J. Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs. Sci Rep. 2019;9:4811 pubmed publisher |
Eiselleova L, Lukjanov V, Farkas S, Svoboda D, Štěpka K, Koutna I. The Role of RNA Polymerase II Contiguity and Long-Range Interactions in the Regulation of Gene Expression in Human Pluripotent Stem Cells. Stem Cells Int. 2019;2019:1375807 pubmed publisher |
Minagawa A, Yoshikawa T, Yasukawa M, Hotta A, Kunitomo M, Iriguchi S, et al. Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy. Cell Stem Cell. 2018;23:850-858.e4 pubmed publisher |
Klein S, Dvornik J, Yarrabothula A, Schaniel C. A Marfan syndrome human induced pluripotent stem cell line with a heterozygous FBN1 c.4082G>A mutation, ISMMSi002-B, for disease modeling. Stem Cell Res. 2017;23:73-76 pubmed publisher |
Lin H, Masaki H, Yamaguchi T, Wada T, Yachie A, Nishimura K, et al. An assessment of the effects of ectopic gp91phox expression in XCGD iPSC-derived neutrophils. Mol Ther Methods Clin Dev. 2015;2:15046 pubmed publisher |
Wu J, Okamura D, Li M, Suzuki K, Luo C, Ma L, et al. An alternative pluripotent state confers interspecies chimaeric competency. Nature. 2015;521:316-21 pubmed publisher |
Wang H, Sridhar B, Leinwand L, Anseth K. Characterization of cell subpopulations expressing progenitor cell markers in porcine cardiac valves. PLoS ONE. 2013;8:e69667 pubmed publisher |
Fekete N, Rojewski M, Furst D, Kreja L, Ignatius A, Dausend J, et al. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS ONE. 2012;7:e43255 pubmed publisher |
Ndonwi M, Girard T, Broze G. The C-terminus of tissue factor pathway inhibitor ? is required for its interaction with factors V and Va. J Thromb Haemost. 2012;10:1944-6 pubmed publisher |
Silk K, Silk J, Ichiryu N, Davies T, Nolan K, Leishman A, et al. Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells. Gene Ther. 2012;19:1035-40 pubmed publisher |
Vaculik C, Schuster C, Bauer W, Iram N, Pfisterer K, Kramer G, et al. Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol. 2012;132:563-74 pubmed publisher |
Ramirez J, Gerbal Chaloin S, Milhavet O, Qiang B, Becker F, Assou S, et al. Brief report: benchmarking human pluripotent stem cell markers during differentiation into the three germ layers unveils a striking heterogeneity: all markers are not equal. Stem Cells. 2011;29:1469-74 pubmed publisher |
Moore J, Atze K, Yeung P, Toro Ramos A, Camarillo C, Thompson K, et al. Efficient, high-throughput transfection of human embryonic stem cells. Stem Cell Res Ther. 2010;1:23 pubmed publisher |
Carvajal Vergara X, Sevilla A, D Souza S, Ang Y, Schaniel C, Lee D, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 2010;465:808-12 pubmed publisher |
Semenov O, Koestenbauer S, Riegel M, Zech N, Zimmermann R, Zisch A, et al. Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. Am J Obstet Gynecol. 2010;202:193.e1-193.e13 pubmed publisher |
Levings P, McGarry S, Currie T, Nickerson D, McClellan S, Ghivizzani S, et al. Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res. 2009;69:5648-55 pubmed publisher |
King F, Ritner C, Liszewski W, Kwan H, Pedersen A, Leavitt A, et al. Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures. Stem Cells Dev. 2009;18:1441-50 pubmed publisher |
Kiprilov E, Awan A, Desprat R, Velho M, Clement C, Byskov A, et al. Human embryonic stem cells in culture possess primary cilia with hedgehog signaling machinery. J Cell Biol. 2008;180:897-904 pubmed publisher |
Galic Z, Kitchen S, Kacena A, Subramanian A, Burke B, Cortado R, et al. T lineage differentiation from human embryonic stem cells. Proc Natl Acad Sci U S A. 2006;103:11742-7 pubmed |
